Cargando…
Molecular mechanisms of anti-tumor properties of P276-00 in head and neck squamous cell carcinoma
BACKGROUND: Tumors of the head and neck present aggressive pathological behavior in patients due to high expression of CDK/CCND1 proteins. P276-00, a novel CDK inhibitor currently being tested in clinic, inhibits growth of several cancers in vitro and in vivo. The pre clinical activity of P276-00 in...
Autores principales: | Mishra, Prabha B, Lobo, Aurelio S, Joshi, Kalpana S, Rathos, Maggie J, Kumar, Gopinath A, Padigaru, Muralidhara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672051/ https://www.ncbi.nlm.nih.gov/pubmed/23414419 http://dx.doi.org/10.1186/1479-5876-11-42 |
Ejemplares similares
-
Molecular evidence for increased antitumor activity of gemcitabine in combination with a cyclin-dependent kinase inhibitor, P276-00 in pancreatic cancers
por: Rathos, Maggie J, et al.
Publicado: (2012) -
Potentiation of in vitro and in vivo antitumor efficacy of doxorubicin by cyclin-dependent kinase inhibitor P276-00 in human non-small cell lung cancer cells
por: Rathos, Maggie J, et al.
Publicado: (2013) -
P276-00, a cyclin-dependent kinase inhibitor, modulates cell cycle and induces apoptosis in vitro and in vivo in mantle cell lymphoma cell lines
por: Shirsath, Nitesh P, et al.
Publicado: (2012) -
Head and neck reconstruction
por: Yadav, Prabha
Publicado: (2013) -
Effect of Gingever® and Probiotics in Dextran Sulfate Sodium (DSS) Induced Ulcerative Colitis in Mice and Its Effects on the Gut Microbiota
por: Fathima, Subiya, et al.
Publicado: (2022)